JD Health International Inc
HKEX:6618
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (35.4), the stock would be worth HK$91.83 (98% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 17.9 | HK$46.32 |
0%
|
| 3-Year Average | 35.4 | HK$91.83 |
+98%
|
| 5-Year Average | 27.6 | HK$71.43 |
+54%
|
| Industry Average | 25.2 | HK$65.26 |
+41%
|
| Country Average | 28.9 | HK$74.9 |
+62%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
HK$104B
|
/ |
Jan 2026
¥4.7B
|
= |
|
|
HK$104B
|
/ |
Dec 2026
¥5.2B
|
= |
|
|
HK$104B
|
/ |
Dec 2027
¥6.5B
|
= |
|
|
HK$104B
|
/ |
Dec 2028
¥8.1B
|
= |
|
|
HK$104B
|
/ |
Dec 2029
¥8.2B
|
= |
|
|
HK$104B
|
/ |
Dec 2030
¥8.3B
|
= |
|
|
HK$104B
|
/ |
Dec 2031
¥9.7B
|
= |
|
|
HK$104B
|
/ |
Dec 2032
¥10.9B
|
= |
|
|
HK$104B
|
/ |
Dec 2033
¥12B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
JD Health International Inc
HKEX:6618
|
148.3B HKD | 17.9 | 24.3 | |
| US |
|
Amazon.com Inc
NASDAQ:AMZN
|
2.8T USD | 34.7 | 36.5 | |
| ZA |
N
|
Naspers Ltd
JSE:NPN
|
703.6B ZAR | 159.8 | 7.5 | |
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
324.1B USD | 24.4 | 24 | |
| CN |
|
PDD Holdings Inc
NASDAQ:PDD
|
139.2B USD | 5.7 | 9.6 | |
| NL |
|
Prosus NV
AEX:PRX
|
98.8B EUR | 490.5 | 8.6 | |
| UY |
|
MercadoLibre Inc
BMV:MELIN
|
1.6T MXN | 28.4 | 46.3 | |
| AR |
|
Mercadolibre Inc
NASDAQ:MELI
|
92.6B USD | 28.4 | 46.4 | |
| US |
D
|
DoorDash Inc
NASDAQ:DASH
|
76.8B USD | 101.4 | 82.2 | |
| CN |
|
Meituan
HKEX:3690
|
507.9B HKD | -12.8 | -19.3 | |
| CN |
|
JD.Com Inc
HKEX:9618
|
377.4B HKD | 48.8 | 16.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 16.6 |
| Median | 28.9 |
| 70th Percentile | 52.9 |
| Max | 49 021 |
Other Multiples
JD Health International Inc
Glance View
JD Health International Inc., a significant arm of the Chinese e-commerce giant JD.com, emerges as a leading force in the digital healthcare landscape. It operates by seamlessly blending technology with healthcare services, providing a multitude of solutions designed to cater to the diverse needs of its users. They have harnessed the power of the internet to offer online medical consultations, a service that connects patients with a network of licensed healthcare professionals. This innovative approach not only broadens access to medical advice and care but also disrupts traditional healthcare models by emphasizing convenience and accessibility. By utilizing advanced algorithms and AI technology, JD Health also offers personalized health management, positioning itself as a pivotal participant in the quest for enriched digital health experiences. The revenue model of JD Health is underpinned by its multifaceted ecosystem, primarily driven by the sale of pharmaceutical products, healthcare merchandise, and the provision of online medical services. They employ a B2C strategy that accounts for most of their sales, utilizing JD.com’s expansive logistics network to ensure swift and reliable delivery. Additionally, the company monetizes its platform by offering premium health-related content and services on a subscription basis, appealing to a broad audience eager to embrace new healthcare paradigms. As the digital transformation of healthcare accelerates, JD Health strategically positions itself to benefit from an expanding market, leveraging its technological expertise and comprehensive service offerings to make healthcare more accessible and efficient for its growing user base.
